Comment Summary

Which topics were given exaggerated importance?
#	Response Date	Response Text
1.	6/6/2008 3:00:00 PM	No
2.	6/6/2008 5:50:00 PM	-
3.	6/6/2008 6:04:00 PM	Drug development stories with the emphasis on the results and not the low-level methodology
4.	6/6/2008 6:26:00 PM	none
5.	6/6/2008 6:26:00 PM	none
6.	6/6/2008 7:40:00 PM	-
7.	6/6/2008 7:41:00 PM	Not that I can think of
8.	6/6/2008 8:52:00 PM	too long description of drug modifications/ improvement for several speakers
9.	6/6/2008 8:59:00 PM	Single researchers' examples were presented rather than general overview or details of the available techniques.
10.	6/6/2008 9:04:00 PM	industrial aspects,
11.	6/6/2008 10:14:00 PM	none
12.	6/6/2008 10:48:00 PM	Too much importance to inhibitor discovery
13.	6/7/2008 12:19:00 PM	nothing
14.	6/7/2008 5:06:00 PM	- Too much on examples of the drug development phase where structural information may no longer be the key element.
15.	6/7/2008 5:27:00 PM	Success story in Drug Design (and not failure case)
16.	6/7/2008 8:40:00 PM	applications of docking and structure based drug design
17.	6/8/2008 8:06:00 AM	none
18.	6/8/2008 7:12:00 PM	----
19.	6/8/2008 11:35:00 PM	Too many detailed examples brought by the speakers. I understand that everyone would like to show his best, but from distant point of view there is no difference between targeting a drug against an enzyme A (first speaker), an enzyme B (second speaker) and enzyme C (third speaker). The two last speakers would better talk about something different
20.	6/9/2008 9:27:00 AM	- none, the balance was correct
21.	6/10/2008 9:38:00 AM	Computational methods
22.	6/10/2008 11:44:00 AM	none
23.	6/10/2008 2:40:00 PM	none, all ok
24.	6/11/2008 4:01:00 PM	general introduction to HTS for drug discovery
25.	6/11/2008 6:46:00 PM	I think there were no topics given exaggerated importance.
26.	6/11/2008 9:51:00 PM	I think some of the CADD/modelling stuff was overdone. And one of the talks, by Mason, was simply incomprehensible.
27.	6/12/2008 7:28:00 AM	historic remarks
28.	6/12/2008 10:10:00 AM	None
29.	6/12/2008 10:49:00 AM	Bioinformatics
30.	6/12/2008 10:55:00 AM	case studies
31.	6/12/2008 11:15:00 AM	too many examples less information
32.	6/12/2008 12:13:00 PM	structures of limited impact on drug discovery/medicine
33.	6/12/2008 3:18:00 PM	GPCRs and Kinases
34.	6/12/2008 3:41:00 PM	history of meetings
35.	6/12/2008 4:36:00 PM	structure-based medicinal chemistry
36.	6/12/2008 7:17:00 PM	Panel debate. Nice idea but the setup was weakly defined and the thing it was replaced with didn't really work.
37.	6/13/2008 1:19:00 AM	career path
38.	6/16/2008 2:00:00 AM	docking
39.	6/22/2008 11:54:00 AM	none
40.	6/25/2008 6:50:00 PM	I find no topic discussed in the meeting exceeded the importance it deserved. They were mostly well covered and optimum.